Diabetes Pro

ADA American Diabetes Association

Advanced Search Help

Home

Professional Education

Journals

Professional Resources

Research Grants

Recognition Programs

Membership

Webcasts

71st Scientific Sessions (2011)
June 24 - 28, 2011
San Diego Convention Center - San Diego, California

List of all the Sessions for this Meeting:

A Physician’s Guide to the Genetics of Personalized Medicine in Diabetes—The Impact of Genetic Forms of Diabetes on Clinical Practice
ADA Education Recognition Program Symposium—Trends in Diabetes Education—Access and Recognition
All in the Family—Community-Based Participatory Research (CBPR) and Diabetes
Atherosclerosis in Type 1 Diabetes—The Same Disease as in Type 2 Diabetes?
Atherosclerotic Cardiovascular Disease and Human Type 1 Diabetes
Atherosclerotic Cardiovascular Disease and Human Type 2 Diabetes
Automated Insulin Delivery Systems—Are They Ready for Prime Time?
Autophagy and Quality Control in the Beta Cell
Autophagy, Aging, and Metabolic Control
Basal Insulin—Is NPH and NPH-Based Premixed Insulin a Competitive Candidate in the Era of Analogs?
Beta Cell Growth and Maintenance
Beta Cell Stimulus Secretion Coupling
Beta Cell Survival in Diabetes
Central Regulation of Food Intake and Obesity
Challenges and Expectations for Obesity Pharmacotherapy
China Medical Tribune Symposium—Type 2 Diabetes in a Chinese Population—Key Clinical Issues
Circadian Regulation of Lipid and Glucose Metabolism
Continuous Glucose Monitoring—How Can We Use It Most Effectively?
Diabetes and Atherosclerosis—Emerging Concepts of Clinical Assessment
Diabetes and Atherosclerosis—Emerging Concepts of Etiology
Diabetes and Dementia—Nutrition and Life Course Considerations
Diabetes Drugs—Do We Need More?
Diabetes Education—Looking Through the Kaleidoscope
Diabetes Educators Preventing Diabetes
Diabetes, Fatty Liver, and Hepatic Insulin Resistance
Drug-Induced Dysglycemia
Epidemiology of Type 1 Diabetes
Epigenetic Control of Beta Cell Maintenance and Reprogramming
Every Bite You Take—Influence of Diet on Metabolism in Pregnancy and Gestational Diabetes Mellitus
Exercise and Diabetes
Exercise, Pregnancy, and Type 2 Diabetes
Experimental Islet Transplantation/Glycemic Control after Kidney Transplantation
Factors Related to Onset and Management of Type 1 Diabetes from Infancy through Adolescence
Facts and Fictions on Beta Cell Preservation in Type 2 Diabetes
Final Results of the SHIELD Study—Epidemiologic and Public Policy Considerations from a Five-Year Prospective Diabetes Mellitus Study
Foot Complications (Includes Roger Pecoraro Lecture)
Four-Year Outcomes of an Intensive Lifestyle Intervention in Type 2 Diabetes
Future Treatment of Vascular-Neural Degenerative Disease
Genetics—Type 1, Type 2, and Complications
HDL and Diabetes—New Developments
Health Outcomes and Health Care Delivery Innovations
Heterogeneity Among Asian Populations in Diabetes and Metabolic Risk
How to Ease the Pain of Diabetic Nerve Disease
Hypoglycemia Unawareness—Possible Mechanisms
Improving Compliance and Outcomes in the Era of Complex Therapeutic Regimens—What Really Works?
Inflammation and Insulin Resistance
Influence of Diabetes on Key Physiological Systems and the Implications for Exercise Capacity
Innate Immunity and Inflammation
Insulin Secretion and Islets—Clinical and Preclinical Studies
Insulin Treatment—Still Room for Improvement?
Intensive Treatment of Diabetes—Focus on Prevention of Hypoglycemia
Is Type 2 Diabetes Mellitus the Best Phenotype for Type 2 Diabetes Epidemiology? The Argument for Sub-Phenotypes
Is Weight Loss the Best Target to Assess the Response to Exercise Training in Patients with Type 2 Diabetes?
Islet Transplantation
It's Not All About Insulin—Other Hormones Affecting Insulin Signaling and Energy Metabolism
Joint ADA/ The Lancet Symposium
Joint ADA/AACC Symposium—Is There a Gold Standard for Diagnosing Diabetes?
Joint ADA/ASN Symposium—New Concepts in Diagnosing and Treating Diabetic Nephropathy
Joint ADA/EASD Symposium—New Ways of Imaging Islets In Vivo
Joint ADA/JDRF Symposium—The Perpetual Question—When Will We Close the Loop? A Progress Update
Joint ADA/TES/EASD Symposium—What Can Be Unified and What Needs To Be Individualized in Obesity and Type 2 Diabetes?
Kelly West Lecture
Last Ten Years of Islet and Pancreas Transplantation
Lifestyle Approaches to Treating Hypertension in Diabetes—Research, Recommendations, and the Real World
Lipid Droplets and Insulin Resistance
Lipids and Lipoproteins
Macronutrients, Food Intake, and the Gut
Mechanisms and Treatment of Type 1 Diabetes
Mechanisms of Kidney Damage—Human and Animal Studies
Mechanisms of Kidney Damage—Human and Animal Studies
Mechanisms Regulating Insulin Signaling and Glucose Uptake
Metabolic Flux, Exercise, and Insulin Sensitivity
Metabolic Pathways at the Crossroads of Diabetes and Cancer
Metabolic Regulators of Insulin Sensitivity
Metabolic Surgery—Effects on Obesity-Related Risk Factors and Gut Hormones Physiology
Mitochondrial Metabolism and Insulin Secretion
Mitochondrial Regulation of Insulin Action and Metabolism
Muscle-Related Studies in Obesity Research
National Scientific & Health Care Achievement Awards Presentation and Outstanding Scientific Achievement Award Lecture
NDEP Symposium—Addressing the New Diabetes Demographics in the U.S.
New Building Blocks of Care and Payment Mechanisms for Diabetes
New Concepts in Brown and White Adipocyte Biology
New Concepts in Diabetic Retinopathy
New Developments in Behavioral Research
New Directions for Islet Cell Replacement
New Therapies for Type 1 Diabetes
Next Generation Sequencing and Its Impact on Diabetes Genetics
Novel Concepts in Diabetic Nephropathy—Basic Science
Novel Mechanisms for Metabolic Regulation
Novel Therapies for Type 2 Diabetes—Today and Tomorrow
Nutrient Excess and ER Stress
Nutrition—Clinical
Obesity and Aging
Obesity and Cancer
Obesity—Animal
Obesity—Human
Ocular Complications
Old Molecules with New Functions in the Islet
Overweight, Obesity, and Type 2 Diabetes in Childhood and Beyond
Peer Support in Diabetes Education
Peripartum Considerations in Obese and Diabetic Women—A Multidisciplinary Perspective
Pharmacoepidemiology and Diabetes—Defining Unexpected Risks and Benefits
Pharmacologic Treatment of Diabetes or Its Complications
Pharmacologic Treatment of Diabetes—Incretin Mimetics
Pharmacologic Treatment of Diabetes—Insulin Therapy
Pharmacologic Treatment of Diabetes—Novel Therapies
Platelets in Diabetes
Positioning Insulin vs. GLP-1 Receptor Agonists in Type 2 Diabetes Mellitus Insufficiently Controlled on Oral Agents
Post-ACCORD—Is Glycemia a Moving Target? Defining and Individualizing Glucose Targets
President, Health Care & Education Address and Outstanding Educator in Diabetes Award Lecture
President, Medicine & Science Address and Banting Medal for Outstanding Scientific Achivement Award Lecture
Professional Section Interest Group Discussion on Behavioral Medicine and Psychology—A Dialogue on Diabetes Control
Professional Section Interest Group Discussion on Clinical Endocrinology, Health Care Delivery, and Public Health—Hypoglycemia and Population Risk—Proposed Mechanisms, Implications for Therapy and Practical Advice for the Clinician
Professional Section Interest Group Discussion on Diabetes in Youth—A Practical Discussion about Transitions from Pediatric to Adult Care
Professional Section Interest Group Discussion on Education—Preparing the Diabetes Educator of the Future
Professional Section Interest Group Discussion on Epidemiology and Statistics—Epidemiology Updates from the National Institutes of Health and the Centers for Disease Control and Prevention
Professional Section Interest Group Discussion on Foot Care—The Year in Review
Professional Section Interest Group Discussion on Nutritional Science and Metabolism—Diabetes and Vitamin D—Are We Ready to Act Now?
Professional Section Interest Group Discussion on Pregnancy and Reproductive Health—Diagnosing Gestational Diabetes—A Continent Divided
Reassessing the Role of AMPK as a Target for Metformin and Insulin Sensitization
Reforming Health Care—Meeting the Challenge with Diabetes Education
Role of the GI Tract in Obesity
Signal Transduction
Signaling in Pancreatic Development
Spanning Bench to Bedside—Diabetes and the Brain
Special Types of Diabetes—Have We Made Any Progress in Management?
Stress and Diabetes
Studies in Childhood Obesity and Type 2 Diabetes
Technology and Behavior Change Across the Lifespan
Technology in Clinical Practice—Help or Hindrance?
The Burgeoning Elderly Diabetes Population—Unique Challenges and Possibilities
The Changing Face of Pre-Existing Diabetes in Pregnancy—Does It Matter for Fetus and Mother?
The Charcot Foot After 142 Years—What Is It and Do We Treat It?
The Costs and Cost Effectiveness of Diabetes Prevention and Care
The Diabetic Foot—Guidelines from the Community
The Dollars and Sense of Diabetes Education
The Experience of Children and Youth with Diabetes—An International Perspective (Includes Behavioral Medicine and Psychology Interest Group Award Lecture for Distinguished Contributions)
The Future of Regulation and Monitoring of Drugs and Devices for Diabetes
The Genetic Architecture of Diabetes and Obesity—Many Ingredients in the Soup
The Role of the Liver in Obesity Research
Tissue Fatty Acid Uptake
TLR-4 Signaling and Insulin Resistance
Transcriptional, Epigenetic, and Physiologic Integration During Pregnancy
Translating DPP Weight Control Interventions from the Research Setting into the Community—2011 Update
Treatment of Insulin Resistance
Treatment of Type 1 Diabetes—Update on Clinical Trials
Type 2 Diabetes Etiology
Type 2 Diabetes Genetics—Association and Function
Type 2 Diabetes Prevention, Complications, and Medications
Unique Pediatric Diabetes Challenges with Technology Implementation and Ongoing Use
Update on Pancreatic Beta Cell Function in Pregnancy and Development—New Pathways/New Mechanisms
Update on Pediatric Immunotherapy and Clinical Trials to Preserve the Beta Cell
What Does Diversity Tell Us About Diabetes Among Hispanics? Trends in the Hispanic Community Health Study/Study of Latinos
A decade of progress in managing T2DM: The retrospective and prospective views Supported by an unresticted educational grant from Sanofi-Aventis
Diabetic Eye Care: Best Practices for Patient Education and Co-Management Supported by an unresticted educational grant from Genentech, A Member of the Roche Group
Emerging Options for Type 2 DM Management: Glucose Control and The Kidney Supported by an unresticted educational grant from Supported by an educational grant from Bristol-Myers Squibb and AstraZeneca LP
HDL and Diabetic Dyslipidemia: Examining the Increased Risk of Atherosclerotic Events in Type 2 Diabetes Supported by an unresticted educational grant from Genentech
Incretin Therapy in Type 2 Diabetes Applied: Navigating and Making Choices in an Ever Changing Environment Supported by an unresticted educational grant from Amylin Pharmaceuticals, Inc., and Lilly USA, LLC
Individualized Medicine in Managing Patients with Type 2 Diabetes Mellitus Supported by an unresticted educational grant from Lilly USA, LLC
Integrating Insulin Pumps and Continuous Glucose Monitoring on the Path Towards Closing the Loop: Practical Applications for Today's Clinician Supported by an unresticted educational grant from Medtronic
Intervenciones Oportunas y Nuevas Terapias: De las Incretinas a las Insulinas en el Horizonte Supported by an unresticted educational grant from Novo Nordisk A/S
Issues in the Management of Hyperclycemia in Patients with Concurrent Kidney Disease Supported by an unresticted educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. which was made possible, in part, through a collaboration with Eli Lilly and Company.
Kidney Disease in Type 2 Diabetes: Disease Progression & Emerging Therapies Supported by an unresticted educational grant from Supported by an educational grant from Reata Pharmaceuticals
Novel, Targeted, & Appropriate PPAR Therapy: New Paradigms for Residual Risk Management Supported by an unresticted educational grant from Genentech
The Evolving Role of GLP-1 Agonists in the Management of Type 2 Diabetes: An Evidence- Based Update Supported by an unresticted educational grant from Novo Nordisk Inc.
The Role of Dopamine in the Brain: Pathophysiology and Treatment Options in Type 2 Diabetes Supported by an unresticted educational grant from Santarus, Inc

Refine Your Search

Title:

Speaker:

Session:

Search Text:

Meeting:

Diabetes Pro

ADA American Diabetes Association

Webcasts

Related Content

Refine Your Search $(function () { $(".SearchTips").tipTip({ defaultPosition: "right", maxWidth: "auto" }); });

Refine Your Search